Drugs / Zopocianine
Zopocianine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06849544 | Apr 2025 → Jul 2026 overdue | metastatic prostate carcinoma | Clinton Bahler | Recruiting | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zopocianine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06849544 ↗ |
| Known as | OTL 0078 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314610 ↗ |
| Known as | OTL 78 | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314610 ↗ |
| Known as | OTL-0078 SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314610 ↗ |
| Known as | OTL78 SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314610 ↗ |
| Known as | Zopocianina | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314610 ↗ |
| Known as | ZOPOCIANINE SODIUM | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314610 ↗ |
| Modality | Small molecule | — CHEMBL5314610 ↗ |